Lavipharm S.A. (ATH:LAVI)
Greece · Delayed Price · Currency is EUR 1.414
-0.012 (-0.84%)
Jul 22, 2026, 5:11 PM EET
Lavipharm Market Cap
Lavipharm has a market cap or net worth of €241.48 million as of July 22, 2026. Its market cap has increased by 69.81% in one year.
Market Cap
241.48M
Enterprise Value
268.15M
Revenue
64.53M
Ranking
n/a
PE Ratio
47.36
Stock Price
€1.41
ChartMarket Cap Chart
Since October 21, 1996, Lavipharm's market cap has increased from 43.03M to 241.48M, an increase of 461.25%. That is a compound annual growth rate of 5.97%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 22, 2026 | 241.48M | 47.58% |
| Dec 31, 2025 | 163.63M | 22.01% |
| Dec 31, 2024 | 134.11M | 0.36% |
| Dec 29, 2023 | 133.62M | 107.29% |
| Dec 30, 2022 | 64.46M | 117.58% |
| Dec 31, 2021 | 29.63M | 23.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ideal Holdings | 315.66M |
| Bank of Greece | 293.01M |
| Intracom Holdings | 250.61M |
| Evropi Holdings Societe Anonyme | 246.57M |
| Dimand | 239.96M |
| Trade Estates REIC | 237.81M |
| Profile Systems & Software | 220.10M |
| Real Consulting | 217.16M |